The trademark application ENGINEUSPROFILE was filed by Molecular Health GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on March 2, 2016, and it was registered by office on June 9, 2016 without any oppositions.
The application was filed in English (German was selected as the second language).
Change of name and address of the trademark registration was recorded on November 30, 2015. Change of name and professional address of the trademark registration was recorded on January 15, 2019. Change of name and professional address of the trademark registration was recorded on January 15, 2019.
Goods And Services
The mark was filed in class 9 with following description of goods:
Downloadable computer databases containing information in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals, life sciences and/or biotechnology
Downloadable computer databases containing medical and/or health information or records about or relating to humans
Downloadable computer software for accessing, organizing, indexing, ranking, integrating, linking, referencing, synthesizing, interpreting and analyzing information from databases in the fields of medicine, health care, genomics, pharmaceuticals, life sciences and/or biotechnology and/or databases containing medical and/or health information or records about or relating to humans
Downloadable mobile applications for mobile devices, such as eg smart phones and/or tablet computers, for accessing, organizing, synthesizing, indexing, ranking, integrating, linking, referencing, interpreting and analyzing information from databases in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals, life sciences and/or biotechnology and/or databases containing medical and/or health information or records about or relating to humans
Downloadable software for generating reports of the results of the data analysis and interpretation relating to a patient's genome or the data generated from molecular tests based on the analysis of genomes, in particular through the application of next generation sequencing (NGS) methods
Medical or laboratory software for DNA and genome analysis in cancer diagnostics, for the diagnosis of genomic changes, and tests at the molecular level, in particular laboratory software for next generation sequencing (NGS), in particular laboratory software for next generation sequencing (NGS) in the context of clinical and medical applications, and software for assisting automated decisions for diagnostic and therapeutic applications
Medical software for pharmacological, pharmacogenetic, molecular and/or biochemical analysis of substances and medicines, in particular for the analysis of the action mechanisms of pharmaceutical preparations, in particular in the field of medicine safety and medicine compatibility
Laboratory software for high resolution and/or highly sensitive analysis of DNA or genomes
Medical or laboratory software for toxicity research in relation to pharmaceutical preparations
Medical or laboratory software for analysis of resistance to pharmaceutical preparations.
The mark was filed in class 10 with following description of goods:
Medical or laboratory device, apparatus and/or equipment for DNA and genome analysis in cancer diagnostics, for the diagnosis of genomic changes, and tests at the molecular level, in particular laboratory device, apparatus and equipment for next generation sequencing (NGS), in particular laboratory device, apparatus and equipment for next generation sequencing (NGS) in the context of clinical and medical applications, and device, apparatus, equipment and/or instruments for assisting automated decisions for diagnostic and therapeutic applications
Medical device, apparatus and/or equipment for pharmacological, pharmacogenetic, molecular and/or biochemical analysis of substances and medicines, in particular for the analysis of the action mechanisms of pharmaceutical preparations, in particular in the field of medicine safety and medicine compatibility
Laboratory device, apparatus and/or equipment for high resolution and/or highly sensitive analysis of DNA or genomes
Medical or laboratory device, apparatus and/or equipment for toxicity research in relation to pharmaceutical preparations
Medical or laboratory device, apparatus and/or equipment for analysis of resistance to pharmaceutical preparations.
The mark was filed in class 38 with following description of goods:
Providing access to searchable databases containing medical, pharmaceutical, biological, clinical and genomic information and/or medical and/or health information or records, molecular test results and/or patient specific data about or relating to humans for scientific research purposes
Providing access to computer software and/or algorithms for use by physicians, clinicians and other healthcare professionals, laboratory personnel, consultants, scientists and other researchers for medical diagnostic and/or treatment and/or drug safety research and/or drug or pharmaceuticals or other treatment discovery, research and/or development
Providing access lo software and/or algorithms for retrieval, integration, correlation, analysis and/or interpretation of genomic data, sequencing data and/or molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and/or medical and/or health information, records or data, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research for medical diagnostic and/or treatment research, and/or drug or pharmaceuticals or other treatment discovery, research and/or development purposes
Providing access to computer software and/or algorithms for use by physicians, clinicians and other healthcare professionals, laboratory personnel, consultants, scientists and other researchers for medical diagnostic and/or treatment purposes
Providing access to software and/or algorithms for retrieval, integration, correlation, analysis and/or interpretation of genomic data, sequencing data and/or molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and/or medical and/or health information, records or data, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research for medical diagnostic and/or treatment purposes
Providing access to databases containing medical, pharmaceutical, biological, clinical, molecular, sequencing and genomic information, disease information, biomarker information and/or medical or health information or records about or relating to humans and/or patient specific data, molecular test results, and/or scientific research for medical diagnostic and/or treatment purposes.
The mark was filed in class 42 with following description of goods:
Consulting and research services in the fields of health care, medicine, life sciences, biotechnology, pharmaceuticals, bioinformatics, genomics and/or pharmaceuticals and pharmaceutical safety for scientific research purposes
Consulting and research services for the retrieval, integration, correlation, analysis and/or interpretation of genomic data, sequencing data, and/or molecular data, disease, biomarkers, drug protocols, drug interactions, clinical profiles, and/or medical and/or health information, records or data, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research for medical diagnostic and/or treatment research and/or drug or pharmaceuticals or other treatment discovery, research and/or development purposes
Designing and/or developing and/or providing use of searchable databases containing medical, pharmaceutical, biological, clinical and genomic information and/or medical and/or health information or records, molecular test results and/or patient specific data about or relating to humans for scientific research purposes
Designing and/or developing and/or providing use of computer software and/or algorithms for use by physicians, clinicians and other healthcare professionals, laboratory personnel, consultants, scientists and other researchers for medical diagnostic and/or treatment and/or drug safety research and/or drug or pharmaceuticals or other treatment discovery, research and/or development
Designing and/or developing and/or providing use of software and/or algorithms for retrieval, integration, correlation, analysis and/or interpretation of genomic data, sequencing data and/or molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and/or medical and/or health information, records or data, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research for medical diagnostic and/or treatment research, and/or drug or pharmaceuticals or other treatment discovery, research and/or development purposes
Research or consulting services featuring software under a software as a Service (SaaS) model for enabling the retrieval, integration, correlation, analysis and/or interpretation of genomic data, sequencing data and molecular data, disease information, biomarker information, drug protocols, drug interactions, clinical profiles, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research and/or health and/or medical information, records or data for medical, diagnostic and/or treatment and/or drug safety research and/or drug or pharmaceuticals or other treatment discovery, research and/or development purposes
Conducting molecular tests based on the analysis of genomes, in particular through the application of next generation sequencing (NGS) methods
Providing services in the field of next generation sequencing (NGS), including analysis and interpretation of the data obtained, in particular data obtained from patients, and analysis and interpretation of changes in his or her genome which contribute to the particular disease of the patient
Making available the results of the data analysis and interpretation relating to a patient's genome or the data generated from molecular tests based on the analysis of genomes, in particular through the application of next generation sequencing (NGS) methods, including, eg in the form of a report
Research services for the retrieval, integration correlation, analysis and/or interpretation of genomic, sequencing and/or molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and/or medical and/or health information, records or data, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research for medical diagnostic and/or treatment purposes
Providing use of computer software and/or algorithms for use by physicians, clinicians and other healthcare professionals, laboratory personnel, consultants, scientists and other researchers for medical diagnostic and/or treatment purposes
Providing use of software and/or algorithms for retrieval, integration, correlation, analysis and/or interpretation of genomic, sequencing and/or molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and/or medical and/or health information, records or data, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research for medical diagnostic and/or treatment purposes
Providing use of databases containing medical, pharmaceutical, biological, clinical, molecular, sequencing and genomic information, disease information, biomarker information and/or medical or health information or records about or relating to humans and/or patient specific data, molecular test results, and/or scientific research for medical diagnostic and/or treatment purposes
Providing information in the fields of life sciences, biotechnology, and bioinformatics.
The mark was filed in class 44 with following description of goods:
Consulting services for the retrieval, integration, correlation, analysis and/or interpretation of genomic, sequencing and/or molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and/or medical and/or health information, records or data, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research for medical diagnostic and/or treatment purposes
Consulting services in the fields of health, medical care, biotechnology, bioinformatics, life sciences, pharmaceuticals and medicine
Providing information in the fields of health, healthcare, pharmaceuticals and pharmaceutical safety, genetic testing for medical purposes
Medical consulting services with respect to the treatment and diagnosis of individuals
Providing pharmaceutical information, including information about drug safety and/or drug compatibility in relation to therapy and the treatment of individuals
Medical consulting services in the fields of diagnostics and patient treatment and treatment protocols
Making available the results of the data analysis and interpretation relating to a patient's genome or the data generated from molecular tests based on the analysis of genomes, in particular through the application of next generation sequencing (NGS) methods, including, eg in the form of a report, to physicians, clinicians and other healthcare professionals, laboratory personnel, consultants, scientists and other researchers for medical diagnostic and/or treatment purposes.